Penumbra Long Term Debt 2014-2022 | PEN

Penumbra long term debt from 2014 to 2022. Long term debt can be defined as the sum of all long term debt fields.
  • Penumbra long term debt for the quarter ending December 31, 2022 was $0.025B, a 6.25% decline year-over-year.
  • Penumbra long term debt for 2022 was $0.025B, a 6.25% decline from 2021.
  • Penumbra long term debt for 2021 was $0.027B, a 2.01% decline from 2020.
  • Penumbra long term debt for 2020 was $0.027B, a 1.19% increase from 2019.
Penumbra Annual Long Term Debt
(Millions of US $)
2022 $25
2021 $27
2020 $27
2019 $27
2018 $
2017 $
2016 $
2015 $
2014 $
2013 $6
Penumbra Quarterly Long Term Debt
(Millions of US $)
2022-12-31 $25
2022-09-30 $25
2022-06-30 $26
2022-03-31 $26
2021-12-31 $27
2021-09-30 $27
2021-06-30 $27
2021-03-31 $27
2020-12-31 $27
2020-09-30 $27
2020-06-30 $26
2020-03-31 $26
2019-12-31 $27
2019-09-30
2019-06-30
2019-03-31
2018-12-31
2018-09-30
2018-06-30
2018-03-31
2017-12-31
2017-09-30
2017-06-30
2017-03-31
2016-12-31
2016-09-30
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2013-12-31 $6
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $10.162B $0.847B
Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $212.206B 23.69
Edwards Lifesciences (EW) United States $49.143B 32.69
Alcon (ALC) Switzerland $32.311B 29.57
STERIS (STE) Ireland $17.996B 22.80
Fresenius Medical Care AG KGaA (FMS) Germany $11.408B 11.93
Teleflex (TFX) United States $11.141B 18.17
Globus Medical (GMED) United States $5.255B 25.31
Integer Holdings (ITGR) United States $2.448B 18.98
Glaukos (GKOS) United States $2.324B 0.00
Paragon 28 (FNA) United States $1.527B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.330B 17.30
Nevro (NVRO) United States $1.089B 0.00
Artivion (AORT) United States $0.488B 240.60